Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 156.60
+0.80 (0.51%)
May 29, 2026, 5:35 PM CET
Ipsen Market Cap
Ipsen has a market cap or net worth of €12.86 billion as of May 29, 2026. Its market cap has increased by 50.94% in one year.
Market Cap
12.86B
Enterprise Value
12.30B
Revenue
3.93B
Ranking
n/a
PE Ratio
29.44
Stock Price
€156.60
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 12.86B, an increase of 623.92%. That is a compound annual growth rate of 10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 12.86B | 31.60% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 91.65B |
| EssilorLuxottica Société anonyme | 80.36B |
| Sartorius Stedim Biotech | 17.00B |
| Eurofins Scientific SE | 10.85B |
| ABIVAX Société Anonyme | 9.04B |
| bioMérieux | 8.64B |
| Virbac | 3.02B |
| emeis Société anonyme | 2.44B |